Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor Oximetry Using Electron Paramagnetic Resonance (EPR) With India Ink (Using Carbon Particulates From Carlo Erba [CE])

NCT03321903 is registered in ClinicalTrials.gov with Philip Schaner as lead sponsor.

NCT NCT03321903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03321903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor Oximetry Using Electron Paramagnetic Resonance (EPR) With India Ink (Using Carbon Particulates From Carlo Erba [CE])
Lead sponsor
Philip Schaner
Phase
Observational
Overall status
Terminated
Start date
August 30, 2017
Completion date
October 27, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm, carcinoma, basal cell, carcinoma, squamous cell, head and neck neoplasms, melanoma, neoplasms, malignant, skin neoplasm